1. Home
  2. MATV vs CTMX Comparison

MATV vs CTMX Comparison

Compare MATV & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mativ Holdings Inc.

MATV

Mativ Holdings Inc.

HOLD

Current Price

$12.20

Market Cap

671.4M

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$3.82

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATV
CTMX
Founded
1995
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
671.4M
596.2M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
MATV
CTMX
Price
$12.20
$3.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$10.00
$6.50
AVG Volume (30 Days)
371.8K
3.4M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
3.25%
N/A
EPS Growth
N/A
50.22
EPS
N/A
0.24
Revenue
$1,982,500,000.00
$113,631,000.00
Revenue This Year
$3.68
N/A
Revenue Next Year
$2.82
N/A
P/E Ratio
N/A
$15.86
Revenue Growth
0.39
N/A
52 Week Low
$4.34
$0.40
52 Week High
$13.57
$4.62

Technical Indicators

Market Signals
Indicator
MATV
CTMX
Relative Strength Index (RSI) 53.86 49.88
Support Level $11.52 $3.42
Resistance Level $13.19 $4.33
Average True Range (ATR) 0.50 0.29
MACD -0.03 -0.01
Stochastic Oscillator 38.54 38.54

Price Performance

Historical Comparison
MATV
CTMX

About MATV Mativ Holdings Inc.

Mativ Holdings Inc is a diversified producer of premium specialty papers and resin-based products. It manufactures and sells paper and reconstituted tobacco products to the tobacco industry as well as specialized paper products. The company operates in two segments namely Advanced Materials and Structures, which manufactures resin-based products used in specialty applications in the filtration, infrastructure and construction, transportation, industrial, and medical end-markets, and Engineered Papers, which produces cigarette papers and reconstituted tobacco products for cigarette and cigar manufacturers, as well as various other non-tobacco paper products.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: